All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.
Educational comparison context for Tirzepatide versus related compounds referenced in research literature. This is documentation for procurement literacy — not protocol or stacking guidance.
Tirzepatide profile
Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide extensively characterised in metabolic pathway research literature. VaultLabs supplies Tirzepatide 30mg lyophilized material for in vitro laboratory research only — not as a medicine.
Type: Incretin dual-agonist peptide
vs related compound: semaglutide
Semaglutide is a selective GLP-1 agonist — dual vs single incretin profiles should not be conflated in documentation.
vs related compound: retatrutide
Retatrutide engages GLP-1, GIP and glucagon pathways — a triple-agonist framework distinct from tirzepatide.
Comparison workflow
Use the peptide stack planner for educational multi-compound review: /tools/peptide-stack-planner
All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.